The purpose of this study is to test whether Meditative Movement (based on a standardized and tested Qigong/Tai Chi Easy protocol) is more efficacious for improving fatigue and other symptoms in women after treatment for breast cancer than (a) a non-meditative "sham" Qigong active intervention and (b) an inactive education / support group.
Patients with breast cancer often report fatigue and other associated symptoms that persist for months, even years, after treatment ends. In a recent pilot study of Qigong/Tai Chi Easy (QG/TCE, a low-intensity form of Meditative Movement), fatigued breast cancer survivors experienced greater improvements in fatigue (medium effect size, .56); compared to a "sham" Qigong control intervention (also low-intensity activity). Trends for improvement compared to control were found for sleep quality and depression. Recruitment for the single-site implementation was steady, and feasible. To build upon the promise of this pilot study, and to further test intervention components that may elucidate what aspects of the intervention have the most impact, a three-group, randomized trial will be undertaken to test effects of an 8-week QG/TCE intervention on fatigue and other symptoms at the end of 8 weeks, and 24 weeks post-intervention. 246 (attrition to 210) women who are 6 months to 10 years past treatment for Stage 0- III breast cancer, aged 45-75, and post-menopausal, will be randomized into one of three study arms. Two comparison groups will be used, an educational support (ES) group control and an active sham Qigong (SQG) group with movements that are similar to and with the same level of physical activity intensity as QG/TCE, but without the focus on the breath and meditative state. These treatments allow for separation of effects associated with gentle exercise alone (controlled in SQG) and education/social support alone without any exercise (controlled in ES) relative to the mind-body practice of QG/TCE, to distinguish unique effects of the meditative and breath foci. The study will be implemented in two sites in a large, metropolitan area, including one low-income hospital (and catchment neighborhood) with larger numbers of Latina survivors where our research team has extensive community connections and cultural experience implementing exercise and meditative movement programs. Psychometrics and biomarkers related to symptoms before and after the interventions will be examined to further our understanding of the mechanisms associated with effects of QG/TCE, as distinct from ES and SQG.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Enrollment
232
Classes will be at two different times of day (to accommodate working and non-working participants). Participants will attend one 60 minute class per week for the 8 weeks, with a recommended home practice time of 2 1/2 hours each week.
Classes will be at two different times of day (to accommodate working and non-working participants). Participants will attend one 60 minute class per week for the 8 weeks, with a recommended home practice time of 2 1/2 hours each week.
Class times and at-home readings correspond to dose set for the QG/TCE and SQG class times and home practice. Participants will attend one 60-minute class per week for the 8 weeks, with a recommended home practice time (reading, workbook completion) of 2 1/2 hours each week.
Arizona State University
Phoenix, Arizona, United States
Fatigue Symptom Inventory
Fatigue
Time frame: Change from baseline fatigue to fatigue at 8 weeks and fatigue at 6 months.
Profile of Mood States Short Form (POMS-SF)
Anxiety and depression
Time frame: Change from baseline anxiety and depression to anxiety and depression at 8 weeks and anxiety and depression at 6 months.
Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG)
Cognitive function
Time frame: Change from baseline cognitive function to cognitive function at 8 weeks and cognitive function at 6 months.
Pittsburgh Sleep Quality Index (PSQI)
Sleep quality
Time frame: Change from baseline sleep quality to sleep quality at 8 weeks and sleep quality at 6 months
Women's Health Initiative Brief Physical Activity Questionnaire (WHI-BPAQ)
Physical activity
Time frame: Change from baseline physical activity (PA) to PA at 8 weeks and PA at 6 months
Venipuncture for serum using MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel kits
Inflammatory biomarkers (IL-1β, IL-6,TNF-α; IFN-γ)
Time frame: Change from baseline Inflammatory biomarkers (IL-1β, IL-6,TNF-α; IFN-γ) to Inflammatory biomarkers at 8 weeks
Diurnal salivary samples (enzyme assay)
Salivary cortisol
Time frame: Change from baseline salivary cortisol to salivary cortisol at 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
ActiGraph GT3X activity monitor
Objective measurement of physical activity
Time frame: Change from baseline objective physical activity to objective physical activity at 8 weeks and objective physical activity at 6 months
ActiGraph GT3X activity monitor
Objective measurement of sleep quality
Time frame: Change from baseline objective sleep quality to objective sleep quality at 8 weeks and objective sleep quality at 6 months